Member Info for BoracicLint

Don't forget 'transformational'!

Can't help feeling this company is doomed. The only viable route seems to be a sale based on cash value. IP is worthless if you can't protect it and Nanoco has patently (forgive the pun) failed to do so. In the continued absence of meaningful commercial deals, it can only burn cash and slowly reduce in value so a sale might only be at a discount to cash.

Harmony Gold Mining Co is up nearly 16% in the US today. As they are our partners in the Jelani JV, could our rise be connected?

So, current Warpaint SP is 630p and a fairly elevated PE ratio of 35, for UK markets.

I have just looked at ELF Beauty: SP $210 (up from about $115 a year ago) and a PE of 95!!!!! It doesn't even pay a divi. It seems a good example of how undervalued UK shares are generally, while US ones are relatively overvalued.

At the end of April I read an article about how high the cyclically-adjusted PE (CAPE) is in the US. It's higher than around 2000 and 2021, which both preceded crashes, and is almost double it's long-term average. If it was to mimic the previous declines it would imply a 40% plus reduction in share prices. However, since then the S&P seems to have resumed it's previous trajectory. Let's hope UK markets keep some optimism, though with the general election, the next few days could be shaky.

Kooba, just wanted to say thanks for your continued level-headed analysis of this share. When the tender was on offer, I agreed with your suggestion that the SP might drift down to the cash value, so offered all of mine and were taken up. TBH it was a relief to be out with a tiny profit that paid for a week's grocery shopping!

Had I stayed in, I would now be sitting on a 30% loss.

I keep watching, thinking perhaps it has bottomed out but try to keep emotion out of it by using the 50 day SMA for guidance. Imagine only a commercial order will make this jump - will this ever happen - we've been waiting aeons?

Good luck to all LTHs, you've been through the grinder. If there were any hills where I live, I'd be like troublesome, put my walking boots on and head for the fells until this turns around.

Today's RNS with the acquisition should give some balance back to the non-consumer division contribution. Market seems to like it at the moment anyway, up a chunky 8%

Just checked my IG account and it has been paid today.

Another great set of results, increase in the divi and slightly ahead expectations for next year. All I can think of is that perhaps some had a price target of 600p and are taking some profits, when you consider the SP has risen by about 50% since last November??? Anyway, I am staying put until a medium-term downtrend happens.

If this is their only product, I can't see it selling in any kind of volume to generate enough profit, even if it were to get through clinical trials. Whilst it may be of help in administering chemo, there are other advances in treatment that are potentially far more effective: https://www.bbc.co.uk/news/world-australia-69006713.

I foolishly invested in SNG, where an Interferon based special administration of Covid treatment offered hope of big profits during the pandemic. Even brokers were touting a potential £75 SP but the clinical trial that promised much was too complicated and couldn't establish efficacy. The SP dropped from £2 ish and continued dribbling down to the current around 6p, despite it having the possibility of treating other illnesses.

A very different product from this one, I know but it does serve to illustrate how risky unproven pharma is.

I think we are better off winding up the company; not even RY will be able to string that out for long. I will be voting NO.

Of all my shares, this has been the most consistent since I bought in 2018. It seems to be always good news and a decent divi to boot, with good divi cover as well. I should probably sell some to have a free ride but my gut says this has further to go...

I don't think it's significant. The industry standard used to be 200mm but now 300mm is the new standard. I imagine most companies in this sector will have to slowly move to the new standard.

Unfortunately, I thought it was a good long-term hold too, buying in originally at 550p in 2014! Since April 2022 it has been flat or in decline but this latest drop looks the worst during recent history.

I am tempted to average down but today's further drop seems for no obvious reason and the overall drop seems OTT. Maybe an II is offloading? Other shares in other sectors seem to suffer similarly huge drops without justification.

Think I might a bit but think there will be a short-term bounce back suitable for a quick few days or weeks trade. The PE here is still high though.

I've been in and out of this share for years and it has done very well, in terms of SP and company performance. However, the SP peaked about 2 years ago at about £20. From the bottom of June 2022 it rose again to about £16 and has been declining since then.

Today's drop seems excessive and mostly based on the Health division caution. The PE ratio shows as 28 on this site, so still pretty high but I think it always has been. The SP now looks good value to me and dividend cover is quite healthy. I think I will be buying back in today.

Mmm, Chairman announced retirement in July, then CEO went and now CFO. It does seem serious and the market obviously doesn't like it. The SP has roughly halved since the recent high in July. On the face of it, the business seems to be doing OK, so what are we not being told?

Looking at the short-term charts, MACD and an SMA that I use have both crossed over, so SP may continue to decline. With that and the coal price, I decided to sell for a very small loss (thanks to the massive divis).

Will keep a watchful eye on this though and may get back in if the SP drops significantly.

Yep, it's an incomprehensible drop. I've been in and out of this share for years and it has always done well and pays a divi to boot. I've used today's drop as an oppo to get back in - I had planned to buy before results and then forgot. A bad memory is sometimes a good thing!

Had an email from my broker today about an EGM, for which the only proposal is THAT THE BALANCE STANDING TO THE CREDIT OF THE SHARE PREMIUM ACCOUNT OF THE COMPANY BE CANCELLED.

Seems this may be the capital reduction but I don't understand what this means either! Can anyone explain please?

It seems a fair offer at £13.50 looking at recent SP history so I will be accepting that. From the RNS, they are also hoping to complete the transaction during Q1 2024.

I wasn't aware of any acquisition talks ongoing and so not aware if there is any likelihood of another bidder entering the fray.

DShares, I am with IG and they send me emails about all GMs and EGMs; just click on the link and it takes me through to Proxyvote.com where I can make my choices. I'd imagine you can go directly to Proxyvote but will need some sort of unique ID your platform should give you.

I'm against all the BOO changes and voted to keep the current Board in place.

It's been a difficult 10 months for all us s/h but looks as if the legacy issues have been mainly sorted out and the trading update suggests Rev is moving into the back for the first time - woohoo!!

BOO trying to start a BoD takeover seems to have no rationale and will only create more inter-company shenanigans, when RevB needs to be left alone to continue its turnaround. It seems Rev will be growing without any "help" from BOO, nor does it need it. I will be voting against any of the BOO proposed changes here.

Main frustration for us all is the share suspension but it looks as if trading will be restored very shortly. I am not convinced it will gap up immediately, but am expecting a big increase in SP over the next year or so.

GLA.

Sorry, this reply was to jg68, not MHL2020.